BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.64 --0%
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q3 EPS of $0.04, $0.14 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $113.4 million versus the consensus estimate of $113.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
